Table 3.
The relationship between STEAP2 expressions and clinicopathological characteristics of breast cancer.
| STEAP2 |
|||||
|---|---|---|---|---|---|
| Clinical characteristics | N | High (%) | Low (%) | χ2 | P |
| Age | 0.250 | 0.617 | |||
| <50 | 80 | 11(13.8%) | 69 (86.2%) | ||
| ≥50 | 165 | 19 (11.5%) | 146 (88.5%) | ||
| Lymph node status (N) | 10.478 | 0.001 | |||
| N0 | 97 | 20 (20.6%) | 77 (79.4%) | ||
| N+ | 148 | 10 (6.8%) | 138 (93.2%) | ||
| TNM clinical stages | 11.867 | 0.001 | |||
| Ⅰ and Ⅱ stage | 108 | 22 (20.4%) | 86 (79.6%) | ||
| Ⅲ and Ⅳ stage | 137 | 8 (5.8%) | 129 (94.2%) | ||
| Pathological type | 0.518 | 0.772 | |||
| Invasive Ductal Carcinoma | 126 | 17 (13.5%) | 109 (86.5%) | ||
| Invasive Lobular Carcinoma | 86 | 10 (11.6%) | 76 (88.4%) | ||
| Invasive special carcinoma | 33 | 3 (9.1%) | 30 (90.9%) | ||
| Histological grade | 10.561 | 0.005 | |||
| Ⅰ grade | 77 | 17 (22.1%) | 60 (77.9%) | ||
| Ⅱ grade | 98 | 9 (9.2%) | 89 (90.8%) | ||
| Ⅲ grade | 70 | 4 (5.7%) | 66 (94.3%) | ||
| Molecular subtype | 1.395 | 0.707 | |||
| Luminal A | 119 | 17 (14.3%) | 102 (85.7%) | ||
| Luminal B | 75 | 9 (12.0%) | 66 (88.0%) | ||
| HER-2 (+) | 27 | 2 (7.4%) | 25 (92.6%) | ||
| Basal-like | 24 | 2 (8.3%) | 22 (91.7%) | ||